Company: Helsinn Birex Therapeutics Ltd. Legal category: Prescription. HT. Sport permitted. Active ingredient: Bicalutamide 50mg. Description: White round biconvex film-coated tablet. Presentation: 28, €105.00. Indication: Advanced prostate cancer in combination with LHRH analogue therapy or surgical castration. Pharmacology: Bicalutamide is a non-steroidal antiandrogen, devoid of other endocrine activity. It binds to androgen receptors without activating [...]

Company: GlaxoSmithKline (Ireland) Ltd. Legal category: Prescription. Sport permitted. Active ingredients: Diphtheria toxoid >2 IU, Tetanus toxoid >20 IU, pertussis toxoid 8 mcg, filamentous haemagglutinin 8 mcg, pertactin2.5mcg, adsorbed on aluminium hydroxide, hydrated (Al(OH)3) and aluminium phosphate (AlPO4). Description: Turbid white suspension for injection in pre-filled syringe. Presentation: 1, price available on request. Indications: Booster [...]

Company: Lundbeck (Ireland) Ltd Legal category: Prescription. Sport permitted. Active ingredient: Prolonged-release melatonin 2mg. Description: White to off-white, round, biconvex prolonged-release tablets. Presentation: 21, €12.33 (wholesale price). Indication: Monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over. Pharmacology: Melatonin is a naturally [...]

Company: Cephalon Pharma (Ireland) Ltd. Legal category: Prescription. GMS. Sport prohibited. Active ingredient: Fentanyl (as citrate) 100mcg, 200mcg, 400mcg, 600mcg, 800mcg. Description: Flat-faced, white, round bevelled-edge tablet, embossed on one side with a C and respectively with 1, 2, 4, 6, 8 on the other side. Presentation: 100mcg-4, €34.84; 200mcg-4, €34.84, 400mcg-4, €34.84, 600mcg-4, €34.84, [...]

Prescription. HT. Sport prohibited. Ipsen Pharmaceuticals Ltd has expanded its short-stature treatment portfolio with the launch of Increlex (mecasermin), a recombinant DNA-derived human insulin-like growth factor-1 (IGF-1). Increlex is the first and only product licensed in Europe for the long term treatment of growth failure in children and adolescents with severe primary insulin-like growth factor-1 [...]

Company: TEVA Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport Permitted. Active ingredient: Venlafaxine (HCl) equivalent to venlafaxine 75mg, 150mg. Description: Opaque hard gelatine prolonged-release capsules containing round, biconvex film-coated tablets, with imprint VEN on cap and strength on body. 75mg: Flesh opaque with two tablets. 150mg: Scarlet with three tablets. Presentation: 75mg-28, €20.23; 150mg-28, €34.68. [...]

Company: Celgene UK and Ireland Ltd. Legal category: Hospital. Sport permitted. Active ingredient: Azacitidine 100mg. Description: White lyophilised powder for suspension for injection. Presentation: 100mg vial. €381.00. Indications: Treatment of adult patients who are not eligible for haematopoietic stem cell transplantation with intermediate-2 and high-risk myelodysplastic syndromes (MDS) according to the International Prognostic Scoring System [...]

Company: UCB (Pharma) Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Lacosamide 50mg, 100mg, 150mg, 200mg (tablets); 15 mg/ml (syrup); 10mg/ml (solution for infusion). Description: Tablets: Respectively, pinkish, dark yellow, salmon or blue oval film-coated tablet debossed with SP on one side and 50, 100, 150 or 200 on the other. Syrup: Clear, [...]